| ||||
Last Loaded on Web: Monday, December 01, 2008
| ||||
Last Loaded on Web: Monday, December 01, 2008
| Database Description |
| Subject Coverage |
| Dialog File Data |
| Contact |
| Terms and Conditions |
Adis R&D Insight comprehensively reports on the latest developments of drugs in active research and development internationally each week. More than 19,000 drugs are included in the database. Drugs reported in Adis R&D Insight start with the earliest laboratory report and continue through to world market launch. Every scientific or commercial development advancing the drug's progress to market is assessed, evaluated, and reported in Adis R&D Insight.
Adis R&D Insight is compiled from information collected from many sources. The primary sources are: direct contact with companies involved with research and development, information collected from drug and therapeutic literature published in over 2,300 medical and biomedical journals, attendance at international meetings and conferences, company annual reports, news services, press releases, and licensed Lehman Brothers' PharmaPipelines data.
Adis editors check all the information before reporting in R&D Insight to ensure the integrity and timeliness of the published information.
File 107 is the public file; File 907 is the subscriber file, available to those who subscribe to a qualifying Wolter Kluwer Health product.
| Dates Covered: | 1986 to present |
|---|---|
| File Size: |
19,000+ records as of April 2005 (File 107)
and 19,000+ records as of April 2005 (File 907) |
| Update Frequency: | Weekly |
|
Adis R&D Insight is provided by Wolters/Kluwer Health. Questions concerning file content should be directed to: Client Services Department 770 Township Line Road, Suite 300 Yardley, PA 19067
| ||||||||
|
Wolters Kluwer Health Client Services Department 250 Waterloo Road London, SE1 8RD United Kingdom
|
For Dialog's Redistribution and Archive Policy, enter HELP ERA online. The following terms and conditions also apply.
Database copyrighted by Wolters/Kluwer Health, Adis International. Data may not be copied or duplicated in hard copy or machine-readable format without written permission of Adis Data Information BV.
If data is to be distributed under Dialog's Redistribution and Archiving (ERA) policy, distribution is restricted to the company and geographical boundaries of the country where the data was downloaded. Data whichhas been downloaded under this provision may not be sold or resold to a third pary outside the company organization.
